Author:
Escamilla Guerrero Guillermo
Reference14 articles.
1. Health Organization, W. (2020). Action framework to advance universal access to safe, effective and quality-assured blood products 2020-2023. Disponible en: https://www.who.int/publications/i/item/9789240000384
2. Hervig TA, Doughty HA, Cardigan RA, Apelseth TO, Hess JR, Noorman F et al. Re?introducing whole blood for transfusion: considerations for blood providers. Vox Sanguinis. 2021; 116 (2): 167-174.
3. Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020; 7 (10): e756-e764.
4. Tanvir EM, Komarova T, Comino E, Sumner R, Whitfield KM, Shaw PN. Effects of storage conditions on the stability and distribution of clinical trace elements in whole blood and plasma: Application of ICP-MS. J Trace Elem Med Biol. 2021; 68: 126804.
5. McCullough J. Quality programs in blood banking and transfusion medicine. Transfusion Medicine. Wiley; 2011. p. 554-572.